Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1993;84(3):237-46.
doi: 10.1007/BF01203656.

Negative-type electroretinogram from cisplatin toxicity

Affiliations
Case Reports

Negative-type electroretinogram from cisplatin toxicity

M F Marmor. Doc Ophthalmol. 1993.

Abstract

A 68-year-old woman with ovarian cancer suffered a loss of visual acuity and color perception after inadvertent overdosage with the antineoplastic agent cisplatin. Her acuity returned to normal but a tritan color defect persisted more than a year later. Her electroretinogram was stable between 7 weeks and 15 months after cisplatin administration, with a negative-type scotopic response, but also reduced cone b waves and a loss of some scotopic oscillatory potentials. With light stimuli between 10 and 100 ms in duration, the photopic on-responses were markedly reduced while the off-responses were normal or close to it. This case suggests that cisplatin may selectively injure on-pathways in the retina and indicates the need to expand the list of disorders that may cause a negative-type electroretinogram.

PubMed Disclaimer

References

    1. Trends Neurosci. 1990 Mar;13(3):110-5 - PubMed
    1. Jpn J Ophthalmol. 1987;31(1):81-7 - PubMed
    1. Ophthalmologica. 1952 Jun;123(6):396-413 - PubMed
    1. Am J Ophthalmol. 1976 May;81(5):606-13 - PubMed
    1. Invest Ophthalmol Vis Sci. 1984 Jul;25(7):787-94 - PubMed

Publication types